Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

About: Aviva Lev-Ari, PhD, RN

Website

http://pharmaceuticalintelligence.wordpress.com

Details

Founder & Director of Leaders in Pharmaceutical Business Intelligence (LPBI) Venture Value Creator @LPBI: VENTURE #1: e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical Open Access Online Scientific Journal http://pharmaceuticalintelligence.com VENTURE #2: BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine http://pharmaceuticalintelligence.com/biomed-e-books/ VENTURE #3: International Scientific Delegations http://pharmaceuticalintelligence.com/scientific-delegation VENTURE #4: Funding, Deals & Partnerships http://pharmaceuticalintelligence.com/joint-ventures/ Corporate Clients for our Services Funding Cardiovascular Medical Devices Development Funding Biologics Development Funding Diagnostics Funding Partnerships in IP Development M&A and Exit Targeting Penetration in New Markets for High Technology Products Management of Engineering Design of Prototypes Outsourcing VENTURE #5: IP Invented HERE! VENTURE # 6: PRESS Coverage of Conferences http://pharmaceuticalintelligence.com/press-coverage/ - University of California, Berkeley, PhD '83 - Stanford University - GSB Exchange Program, 1980/81 - Northeastern University, Biological Sciences & Nursing '07 Worked at Director level with Start-ups and Fortune 100 companies making presentations at the CEO Board Room level. Start ups: TimeØ Group, Concept Five Technologies, Inc., MDSS, Inc.; Top Tier Management Consulting: SRI International, Monitor Group; OEM: Amdahl Corporation; Top 6th System Integrator: Perot System Corporation; FFRDC: MITRE Corporation. In the Publishing industry: McGraw-Hill/CTB. Researcher on Cardiovascular Pharmaco-therapy at Bouve College of Health Sciences, Northeastern University.

Posts by Aviva Lev-Ari, PhD, RN:

• August 3, 2026 Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How?

• July 19, 2026 AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models

• June 15, 2026 Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma

• June 11, 2026 A Systematic Analysis of Competitive Dynamics in the AI Revolution — Strategic Relevance to LPBI Group’s Mission – Alex Wissner-Gross Daily Newsletters by KOL (March 1 – June 10, 2026, to be extended to Present)

• May 26, 2026 Top VC Investors in AI / Health AI in 2026

• January 31, 2026 Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983.

• January 24, 2026 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos

• January 12, 2026 Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality

• January 11, 2026 Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry

• January 10, 2026 List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter

Older Posts »